These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 4308926

  • 1. Duration of application and change of a regimen with secondary drugs.
    Oka S, Takase Y, Kato S.
    Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):46-9. PubMed ID: 4308926
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment with secondary antitubercular agents].
    Ovreberg K.
    Tidsskr Nor Laegeforen; 1968 May 01; 88(9):741-9. PubMed ID: 4298856
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
    Aoyagi T, Fukuhara Y, Hondo G, Matsumiya T, Murata A.
    Kekkaku; 1970 Jan 01; 45(1):27-36. PubMed ID: 5416951
    [No Abstract] [Full Text] [Related]

  • 10. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
    Steininger WJ.
    Bull Int Union Tuberc; 1968 Dec 01; 41():181-2. PubMed ID: 4303861
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of patients with drug-resistance in economically developed countries.
    Crofton J.
    Tubercle; 1969 Mar 01; 50():Suppl:65-8. PubMed ID: 4319134
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis.
    Kitamoto O, Oka S, Kawamori Y, Gomi J, Sugiyama K.
    Jpn J Tuberc Chest Dis; 1970 Jul 01; 16(1):1-13. PubMed ID: 4990959
    [No Abstract] [Full Text] [Related]

  • 18. [Intravenous chemotherapy of pulmonary tuberculosis].
    Ivaniuta OM.
    Vrach Delo; 1971 Jan 01; (1):84-7. PubMed ID: 4325153
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.